Epidemiology of lung cancer and lung cancer screening programs in China and the United States

Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contri...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters Vol. 468; pp. 82 - 87
Main Authors: Yang, Dawei, Liu, Yang, Bai, Chunxue, Wang, Xiandong, Powell, Charles A.
Format: Journal Article
Language:English
Published: Clare Elsevier B.V 01.01.2020
Elsevier Limited
Subjects:
ISSN:0304-3835, 1872-7980, 1872-7980
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women. •Recently, the lung cancer motality rate has decreased gradually in the US while it is still increasing in China.•The decline in smoking prevalence and impact of clean air legislation are main contributors to the falling trend in the US.•In China, the crude mortality rate is highest in more developed areas (the east coast) with highest levels of ambient fine particulate matter (PM2.5).•Lung cancer screening impact in China may increase by including women with high exposures to PM2.5 and environmental tobacco smoke.
AbstractList Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.
Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women. •Recently, the lung cancer motality rate has decreased gradually in the US while it is still increasing in China.•The decline in smoking prevalence and impact of clean air legislation are main contributors to the falling trend in the US.•In China, the crude mortality rate is highest in more developed areas (the east coast) with highest levels of ambient fine particulate matter (PM2.5).•Lung cancer screening impact in China may increase by including women with high exposures to PM2.5 and environmental tobacco smoke.
Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.
Author Yang, Dawei
Liu, Yang
Powell, Charles A.
Wang, Xiandong
Bai, Chunxue
Author_xml – sequence: 1
  givenname: Dawei
  orcidid: 0000-0002-8928-143X
  surname: Yang
  fullname: Yang, Dawei
  organization: Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 2
  givenname: Yang
  orcidid: 0000-0001-6557-6439
  surname: Liu
  fullname: Liu, Yang
  organization: Department of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA
– sequence: 3
  givenname: Chunxue
  surname: Bai
  fullname: Bai, Chunxue
  organization: Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
– sequence: 4
  givenname: Xiandong
  surname: Wang
  fullname: Wang, Xiandong
  email: xiangdong.wang@clintransmed.org
  organization: Zhongshan Hospital Institute for Clinical Science, Shanghai Medical College, Fudan University, Shanghai, China
– sequence: 5
  givenname: Charles A.
  surname: Powell
  fullname: Powell, Charles A.
  email: charles.powell@mssm.edu
  organization: Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
BookMark eNqFkE1rGzEQhkVJoE7Sf9DDQi-9rDvalfYjhEAwaVMI9JDkGIQqjRy5suRKcsD_Ptq6l_jik9DwvC8zzxk58cEjIZ8pzCnQ7ttqrqR3mOcN0LGM5gDjBzKjQ9_U_TjACZlBC6xuh5Z_JGcprQCAs57PyPPtxmpc2-DCclcFU7mtX1alTmGspNfv_klFRG_LYBPDMsp1qqyvFi_Wy39sfsHqyduMunrIMmO6IKdGuoSf_r_n5PH77ePirr7_9ePn4ua-VqyBXGuDhnX0N1OGG0YHo7mSnEo-ak77oeODYqaRkvZcA22bsesaxWinaMuNgvacfN3XlrX-bjFlsbZJoXPSY9gm0bTAi4ChndAvB-gqbKMvyxWK0hEYg4m63FMqhpQiGqFsOcgGn6O0TlAQk3ixEnvxYhI_TYv4EmYH4U20axl3x2LX-xgWUa8Wo0jKYvGubUSVhQ72WMHVQYFy1lsl3R_cHY-_AdZ1tMo
CitedBy_id crossref_primary_10_3389_fonc_2024_1339036
crossref_primary_10_1038_s41598_024_71602_0
crossref_primary_10_1016_j_jff_2024_106375
crossref_primary_10_1007_s10555_023_10142_x
crossref_primary_10_1016_j_ecoenv_2021_112703
crossref_primary_10_1016_j_mattod_2021_02_018
crossref_primary_10_3390_atmos12081068
crossref_primary_10_1016_j_phymed_2023_154682
crossref_primary_10_3389_fonc_2022_1049096
crossref_primary_10_1016_j_ejmech_2024_116952
crossref_primary_10_1038_s41419_023_05992_w
crossref_primary_10_3390_jcm9082473
crossref_primary_10_1038_s41598_024_79657_9
crossref_primary_10_1158_1940_6207_CAPR_21_0155
crossref_primary_10_1007_s11033_022_07126_5
crossref_primary_10_1038_s41392_021_00745_7
crossref_primary_10_1097_MD_0000000000026367
crossref_primary_10_1097_MD_0000000000030760
crossref_primary_10_1016_j_canlet_2020_12_040
crossref_primary_10_1016_j_cca_2020_05_043
crossref_primary_10_1038_s41598_024_69994_0
crossref_primary_10_1111_1759_7714_15170
crossref_primary_10_1097_MD_0000000000037836
crossref_primary_10_1016_j_tranon_2024_101989
crossref_primary_10_3390_cancers15061718
crossref_primary_10_1186_s12885_022_10036_1
crossref_primary_10_1515_reveh_2024_0171
crossref_primary_10_2147_CMAR_S281663
crossref_primary_10_3389_fonc_2025_1542067
crossref_primary_10_1038_s41598_021_88643_4
crossref_primary_10_1016_j_jtho_2022_09_220
crossref_primary_10_1002_prm2_12124
crossref_primary_10_3389_fimmu_2023_1233260
crossref_primary_10_1016_j_jtho_2023_05_024
crossref_primary_10_1177_17449871241246971
crossref_primary_10_1007_s10735_024_10251_z
crossref_primary_10_1186_s40779_025_00645_9
crossref_primary_10_1165_rcmb_2023_0448TR
crossref_primary_10_1016_j_canlet_2020_03_008
crossref_primary_10_7717_peerj_16540
crossref_primary_10_1007_s10653_021_00833_1
crossref_primary_10_1038_s41598_024_55475_x
crossref_primary_10_3389_fonc_2021_697247
crossref_primary_10_1371_journal_pone_0320931
crossref_primary_10_1016_j_ecoenv_2022_114039
crossref_primary_10_4081_ejh_2023_3784
crossref_primary_10_1186_s12885_025_13710_2
crossref_primary_10_1007_s10812_025_01893_2
crossref_primary_10_3389_fmed_2025_1609322
crossref_primary_10_1016_j_ecoenv_2023_115792
crossref_primary_10_1002_cac2_12099
crossref_primary_10_1002_cam4_4638
crossref_primary_10_1097_MS9_0000000000003593
crossref_primary_10_3389_bjbs_2022_10598
crossref_primary_10_1111_hex_13426
crossref_primary_10_3389_fphar_2021_665253
crossref_primary_10_1186_s41065_025_00426_3
crossref_primary_10_1002_cam4_70184
crossref_primary_10_1002_ijc_34681
crossref_primary_10_1016_j_lungcan_2025_108754
crossref_primary_10_1016_j_radi_2021_12_006
crossref_primary_10_1093_labmed_lmac122
crossref_primary_10_3389_fonc_2022_995870
crossref_primary_10_1002_ijc_70066
crossref_primary_10_2196_56590
crossref_primary_10_1016_j_tranon_2024_102182
crossref_primary_10_1016_j_sna_2024_115637
crossref_primary_10_1016_j_ejps_2022_106119
crossref_primary_10_2217_fon_2021_0045
crossref_primary_10_1002_hsr2_1333
crossref_primary_10_1186_s13019_024_02635_9
crossref_primary_10_1016_j_ajem_2024_02_019
crossref_primary_10_4081_mrm_2023_929
crossref_primary_10_1186_s12885_025_13562_w
crossref_primary_10_1097_RTI_0000000000000613
crossref_primary_10_1186_s13550_021_00801_x
crossref_primary_10_1111_ina_13120
crossref_primary_10_1080_10408444_2019_1700210
crossref_primary_10_1016_j_ejphar_2022_174797
crossref_primary_10_1186_s12951_022_01455_0
crossref_primary_10_1016_j_heliyon_2022_e09953
crossref_primary_10_2147_OTT_S351085
crossref_primary_10_3390_ijerph20085522
crossref_primary_10_1016_j_chemosphere_2023_140358
crossref_primary_10_3389_fimmu_2025_1595408
crossref_primary_10_2147_IJGM_S330681
crossref_primary_10_2217_fon_2023_0469
crossref_primary_10_3389_fonc_2021_585388
crossref_primary_10_1016_j_puhe_2023_12_005
crossref_primary_10_1007_s11010_020_03936_y
crossref_primary_10_1007_s11427_024_2810_y
crossref_primary_10_1007_s00432_021_03879_x
crossref_primary_10_1001_jamanetworkopen_2023_46994
crossref_primary_10_1016_j_lfs_2020_118797
crossref_primary_10_1155_2022_6910126
crossref_primary_10_3390_cancers15020476
crossref_primary_10_1186_s12935_024_03347_9
crossref_primary_10_1155_2022_5501171
crossref_primary_10_3389_fonc_2020_01356
crossref_primary_10_3389_fonc_2022_1005924
crossref_primary_10_1016_j_ebiom_2022_103951
crossref_primary_10_1007_s12032_021_01638_z
crossref_primary_10_1186_s12871_023_02266_y
crossref_primary_10_1007_s11748_020_01576_z
crossref_primary_10_5812_ijcm_135020
crossref_primary_10_1038_s41419_020_2706_7
crossref_primary_10_1155_2022_1112987
crossref_primary_10_1038_s41598_021_02330_y
crossref_primary_10_2147_CMAR_S327022
crossref_primary_10_2147_CMAR_S516235
crossref_primary_10_7717_peerj_14668
crossref_primary_10_3389_fphar_2022_949835
crossref_primary_10_12998_wjcc_v11_i31_7593
crossref_primary_10_1016_j_jbc_2025_110596
crossref_primary_10_1097_MD_0000000000037431
crossref_primary_10_1038_s41598_025_10185_w
crossref_primary_10_1177_0300060520937163
crossref_primary_10_1016_j_cllc_2023_02_009
crossref_primary_10_1016_j_nanoms_2021_12_001
crossref_primary_10_1002_cac2_12393
crossref_primary_10_1007_s11010_022_04359_7
crossref_primary_10_1002_cam4_6993
crossref_primary_10_1186_s12885_021_07946_x
crossref_primary_10_3389_fonc_2024_1427170
crossref_primary_10_3389_fmed_2023_1286433
crossref_primary_10_1097_PAI_0000000000001266
crossref_primary_10_1007_s11427_022_2240_6
crossref_primary_10_1155_2022_2381018
crossref_primary_10_1186_s12885_020_07750_z
crossref_primary_10_1109_JBHI_2022_3171851
crossref_primary_10_3389_fphar_2022_827520
crossref_primary_10_1111_1759_7714_15323
crossref_primary_10_1177_1724600820967124
crossref_primary_10_1016_j_sab_2021_106200
crossref_primary_10_1016_j_tranon_2025_102486
crossref_primary_10_2196_33633
crossref_primary_10_1186_s12885_022_09599_w
crossref_primary_10_4103_jcrt_jcrt_1485_21
crossref_primary_10_1002_ptr_8242
crossref_primary_10_3389_fonc_2024_1511530
crossref_primary_10_1007_s12094_024_03619_w
crossref_primary_10_1186_s12889_025_21979_y
crossref_primary_10_1007_s00432_022_04253_1
crossref_primary_10_1038_s44321_024_00175_2
crossref_primary_10_3389_fphar_2021_649222
crossref_primary_10_1097_CM9_0000000000002977
crossref_primary_10_1002_adhm_202301561
crossref_primary_10_1016_j_cej_2024_153784
crossref_primary_10_1016_j_cpcardiol_2023_102094
crossref_primary_10_1016_j_ctarc_2021_100462
crossref_primary_10_1186_s12882_024_03623_w
crossref_primary_10_1016_j_lungcan_2024_107889
crossref_primary_10_1109_ACCESS_2022_3215706
crossref_primary_10_1007_s12010_023_04739_9
crossref_primary_10_1038_s41598_024_62126_8
crossref_primary_10_3892_ol_2021_13155
crossref_primary_10_1080_2162402X_2021_1959977
crossref_primary_10_1080_10934529_2024_2331938
crossref_primary_10_1038_s41598_023_29012_1
crossref_primary_10_1186_s12885_021_07811_x
crossref_primary_10_1111_imj_16202
crossref_primary_10_1002_ctm2_486
crossref_primary_10_1007_s12011_020_02240_6
crossref_primary_10_1111_jebm_12476
crossref_primary_10_3389_fonc_2022_937277
crossref_primary_10_3390_diagnostics12102317
crossref_primary_10_1007_s10147_021_02108_2
crossref_primary_10_1186_s12890_023_02410_x
crossref_primary_10_1097_MD_0000000000032861
crossref_primary_10_1186_s13045_020_00915_0
crossref_primary_10_1186_s12890_024_02997_9
crossref_primary_10_1016_j_biochi_2025_03_002
crossref_primary_10_1186_s12940_023_00976_x
crossref_primary_10_3390_cancers17030534
crossref_primary_10_3389_fpubh_2024_1388140
crossref_primary_10_3389_fonc_2025_1637366
crossref_primary_10_1002_ijc_34741
crossref_primary_10_1097_CM9_0000000000002161
crossref_primary_10_3390_epidemiologia5040053
crossref_primary_10_1007_s00432_022_04555_4
crossref_primary_10_1007_s12149_024_01964_y
crossref_primary_10_3390_ijerph19169971
crossref_primary_10_1007_s00432_022_04539_4
crossref_primary_10_1371_journal_pone_0291178
crossref_primary_10_1016_j_heliyon_2023_e23207
crossref_primary_10_1039_D1NR02418C
crossref_primary_10_1016_j_phymed_2020_153370
crossref_primary_10_3389_fgene_2021_755245
crossref_primary_10_1186_s13244_025_01937_3
crossref_primary_10_1007_s11769_022_1305_1
crossref_primary_10_3389_fcimb_2022_937864
crossref_primary_10_1111_cas_70113
crossref_primary_10_1038_s41746_024_01309_z
crossref_primary_10_1002_cam4_5886
crossref_primary_10_1007_s10555_024_10177_8
crossref_primary_10_1016_j_lanwpc_2024_101030
crossref_primary_10_1016_j_eclinm_2024_103033
crossref_primary_10_1001_jamanetworkopen_2021_29126
crossref_primary_10_1007_s00500_023_09341_z
crossref_primary_10_3389_fpubh_2021_650392
crossref_primary_10_3892_ol_2024_14361
Cites_doi 10.1371/journal.pone.0173119
10.1164/ajrccm.165.2.ats01
10.1016/j.cllc.2016.03.004
10.1016/j.scitotenv.2016.11.147
10.1002/cncr.29571
10.1002/cncr.29560
10.1016/S0169-5002(99)00093-8
10.21037/tlcr.2018.05.14
10.1016/j.lungcan.2011.05.021
10.1111/1759-7714.12078
10.1001/jama.291.14.1763
10.1093/ije/25.5.907
10.1097/EDE.0b013e318181b3ca
10.1158/1055-9965.EPI-10-0036
10.1158/0008-5472.CAN-11-1590
10.1016/S1470-2045(13)70487-X
10.1016/S1470-2045(19)30329-8
10.1148/radiol.14132950
10.1001/jamaoncol.2016.6416
10.1200/JCO.2006.07.2983
10.1056/NEJMoa1102873
10.1002/cncr.29677
10.18632/oncotarget.17313
10.1111/1759-7714.12253
10.1038/nature15371
10.1056/NEJMoa1817364
10.1148/radiol.2213001643
10.1097/JTO.0b013e31818020eb
10.1148/radiol.2015142554
10.1016/S0169-5002(01)00416-0
10.2214/AJR.16.16930
10.1164/rccm.200504-615OC
10.1097/JTO.0b013e3181c8cc0c
10.1073/pnas.0905756106
ContentType Journal Article
Copyright 2019 Elsevier B.V.
2019. Elsevier B.V.
Copyright © 2019 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2019 Elsevier B.V.
– notice: 2019. Elsevier B.V.
– notice: Copyright © 2019 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
7TO
7U9
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.canlet.2019.10.009
DatabaseName CrossRef
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1872-7980
EndPage 87
ExternalDocumentID 10_1016_j_canlet_2019_10_009
S0304383519305002
GeographicLocations United States--US
China
GeographicLocations_xml – name: China
– name: United States--US
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
4.4
457
4CK
4G.
5GY
5RE
5VS
6J9
6PF
7-5
71M
8FE
8FH
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACLOT
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CS3
DU5
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
K-O
KOM
LK8
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SPCBC
SSH
SSU
SSZ
T5K
Z5R
~G-
~HD
7RV
7X7
8C1
8FI
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKRA
AFKWA
AJOXV
AMFUW
AZQEC
BBNVY
BENPR
BHPHI
DOVZS
FYUFA
GUQSH
HCIFZ
LCYCR
M1P
M2M
M2O
M7P
.55
.GJ
3O-
53G
9DU
AAQXK
AAYXX
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
AFFNX
AFJKZ
AGQPQ
AGRDE
AI.
AIGII
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HED
HMK
HMO
HVGLF
HZ~
R2-
SAE
SEW
UDS
VH1
WUQ
X7M
ZGI
7TO
7U9
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c420t-dfef461b4cf5f418fd5ca51a59d5178658c4f2aa175d01329662c416c135fc03
ISICitedReferencesCount 260
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000497256700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0304-3835
1872-7980
IngestDate Sun Sep 28 00:46:19 EDT 2025
Tue Oct 07 06:24:32 EDT 2025
Sat Nov 29 07:21:19 EST 2025
Tue Nov 18 20:50:52 EST 2025
Fri Feb 23 02:42:37 EST 2024
Tue Oct 14 19:30:14 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords LDCT
ETS
Mortality
PM2.5
Incidence
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c420t-dfef461b4cf5f418fd5ca51a59d5178658c4f2aa175d01329662c416c135fc03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8928-143X
0000-0001-6557-6439
PQID 2311904400
PQPubID 2031080
PageCount 6
ParticipantIDs proquest_miscellaneous_2305030830
proquest_journals_2311904400
crossref_citationtrail_10_1016_j_canlet_2019_10_009
crossref_primary_10_1016_j_canlet_2019_10_009
elsevier_sciencedirect_doi_10_1016_j_canlet_2019_10_009
elsevier_clinicalkey_doi_10_1016_j_canlet_2019_10_009
PublicationCentury 2000
PublicationDate 2020-01-01
2020-01-00
20200101
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Clare
PublicationPlace_xml – name: Clare
PublicationTitle Cancer letters
PublicationYear 2020
Publisher Elsevier B.V
Elsevier Limited
Publisher_xml – name: Elsevier B.V
– name: Elsevier Limited
References Huang, Pan, Wu, Chen, Chen (bib24) 2017; 8
Howard, Richards, Bach, Kegler, Berg (bib41) 2015; 121
Jemal, Fedewa (bib9) 2017; 3
Yip, Henschke, Xu, Li, Jirapatnakul, Yankelevitz (bib31) 2017; 208
Zhong, Goldberg, Parent, Hanley (bib18) 2000; 27
Raaschou-Nielsen, Bak, Sorensen, Jensen, Ketzel, Hvidberg, Schnohr, Tjonneland, Overvad, Loft (bib22) 2010; 19
Yatabe, Borczuk, Powell (bib37) 2011; 74
Li, Chen, Zhang, Chen, Dai, Zou (bib14) 2011; 14
Toonkel, Borczuk, Powell (bib36) 2010; 5
(bib39) 2011; 365
Chen, Peto, Iona, Guo, Chen, Bian, Yang, Zhang, Lu, Chen, Collins, Li, China Kadoorie Biobank Collaborative (bib15) 2015; 121
Patz, Black, Goodman (bib13) 2001; 221
Hu, Qian, Bai (bib40) 2015; 121
Zhou, Fan, Wu, Huang, Wang, Li, Liu, Wang, Li, Qiao (bib12) 2014; 5
Yankelevitz, Yip, Smith, Liang, Liu, Xu, Salvatore, Wolf, Flores, Henschke (bib32) 2015; 277
Borczuk, Kim, Yegen, Friedman, Powell (bib34) 2005; 172
Patel, Bach, Kris (bib16) 2004; 291
Lelieveld, Evans, Fnais, Giannadaki, Pozzer (bib20) 2015; 525
Sheehan, Criss, Gazelle, Pandharipande, Kong (bib27) 2017; 12
Zhou, Zhou (bib7) 2018; 7
Henschke, Yankelevitz, Smith, Miettinen (bib8) 2002; 35
Beelen, Hoek, van den Brandt, Goldbohm, Fischer, Schouten, Armstrong, Brunekreef (bib21) 2008; 19
Liu, Chen, Sera, Vicedo-Cabrera, Guo, Tong, Coelho, Saldiva, Lavigne, Matus, Valdes Ortega, Osorio Garcia, Pascal, Stafoggia, Scortichini, Hashizume, Honda, Hurtado-Díaz, Cruz, Nunes, Teixeira, Kim, Tobias, Íñiguez, Forsberg, Åström, Ragettli, Guo, Chen, Bell, Wright, Scovronick, Garland, Milojevic, Kyselý, Urban, Orru, Indermitte, Jaakkola, Ryti, Katsouyanni, Analitis, Zanobetti, Schwartz, Chen, Wu, Cohen, Gasparrini, Kan (bib29) 2019; 381
Yip, Henschke, Yankelevitz, Smith (bib30) 2014; 273
Loomis, Grosse, Lauby-Secretan, El Ghissassi, Bouvard, Benbrahim-Tallaa, Guha, Baan, Mattock, Straif (bib19) 2013; 14
Luo, Luo, Wampfler, Wang, Liu, Chen, Adjei, Midthun, Yang (bib28) 2019; 20
Zhang, Tao, Shen, Ma (bib25) 2009; 106
Barta, Powell, Wisnivesky (bib3) 2019
Fang, Madhavan, Alderman (bib5) 1996; 25
Dai, Li (bib10) 2013; 47
Wu, Huang, Wu, Tang, Chen, Mar, Yen, Wu (bib33) 2016; 17
Borczuk, Sole, Lu, Chen, Wilgus, Friedman, Albelda, Powell (bib35) 2011; 71
Nana-Sinkam, Powell (bib38) 2013; vol. 143
Mazzone, Powell, Arenberg, Bach, Detterbeck, Gould, Jaklitsch, Jett, Naidich, Vachani, Wiener, Silvestri (bib26) 2014
Women and Smoking (bib17) 2001
Wakelee, Chang, Gomez, Keegan, Feskanich, Clarke, Holmberg, Yong, Kolonel, Gould, West (bib6) 2007; 25
(bib2) 2002; 165
Zhao, Wu (bib11) 2015; 6
Chen, Zheng, Baade, Zhang, Zeng, Bray, Jemal, Yu, He (bib1) 2016; 66
Guo, Zeng, Zheng, Li, Pereira, Liu, Chen, Huxley (bib23) 2017; 579
Youlden, Cramb, Baade (bib4) 2008; 3
Beelen (10.1016/j.canlet.2019.10.009_bib21) 2008; 19
(10.1016/j.canlet.2019.10.009_bib2) 2002; 165
Yip (10.1016/j.canlet.2019.10.009_bib31) 2017; 208
Li (10.1016/j.canlet.2019.10.009_bib14) 2011; 14
Zhong (10.1016/j.canlet.2019.10.009_bib18) 2000; 27
Guo (10.1016/j.canlet.2019.10.009_bib23) 2017; 579
Mazzone (10.1016/j.canlet.2019.10.009_bib26) 2014
Chen (10.1016/j.canlet.2019.10.009_bib15) 2015; 121
Women and Smoking (10.1016/j.canlet.2019.10.009_bib17) 2001
Loomis (10.1016/j.canlet.2019.10.009_bib19) 2013; 14
Henschke (10.1016/j.canlet.2019.10.009_bib8) 2002; 35
Toonkel (10.1016/j.canlet.2019.10.009_bib36) 2010; 5
(10.1016/j.canlet.2019.10.009_bib39) 2011; 365
Zhou (10.1016/j.canlet.2019.10.009_bib7) 2018; 7
Lelieveld (10.1016/j.canlet.2019.10.009_bib20) 2015; 525
Jemal (10.1016/j.canlet.2019.10.009_bib9) 2017; 3
Howard (10.1016/j.canlet.2019.10.009_bib41) 2015; 121
Patel (10.1016/j.canlet.2019.10.009_bib16) 2004; 291
Yip (10.1016/j.canlet.2019.10.009_bib30) 2014; 273
Zhou (10.1016/j.canlet.2019.10.009_bib12) 2014; 5
Raaschou-Nielsen (10.1016/j.canlet.2019.10.009_bib22) 2010; 19
Yankelevitz (10.1016/j.canlet.2019.10.009_bib32) 2015; 277
Hu (10.1016/j.canlet.2019.10.009_bib40) 2015; 121
Wakelee (10.1016/j.canlet.2019.10.009_bib6) 2007; 25
Huang (10.1016/j.canlet.2019.10.009_bib24) 2017; 8
Liu (10.1016/j.canlet.2019.10.009_bib29) 2019; 381
Zhao (10.1016/j.canlet.2019.10.009_bib11) 2015; 6
Luo (10.1016/j.canlet.2019.10.009_bib28) 2019; 20
Patz (10.1016/j.canlet.2019.10.009_bib13) 2001; 221
Youlden (10.1016/j.canlet.2019.10.009_bib4) 2008; 3
Zhang (10.1016/j.canlet.2019.10.009_bib25) 2009; 106
Borczuk (10.1016/j.canlet.2019.10.009_bib35) 2011; 71
Fang (10.1016/j.canlet.2019.10.009_bib5) 1996; 25
Dai (10.1016/j.canlet.2019.10.009_bib10) 2013; 47
Sheehan (10.1016/j.canlet.2019.10.009_bib27) 2017; 12
Yatabe (10.1016/j.canlet.2019.10.009_bib37) 2011; 74
Barta (10.1016/j.canlet.2019.10.009_bib3) 2019
Nana-Sinkam (10.1016/j.canlet.2019.10.009_bib38) 2013; vol. 143
Wu (10.1016/j.canlet.2019.10.009_bib33) 2016; 17
Chen (10.1016/j.canlet.2019.10.009_bib1) 2016; 66
Borczuk (10.1016/j.canlet.2019.10.009_bib34) 2005; 172
References_xml – volume: 3
  start-page: 1278
  year: 2017
  end-page: 1281
  ident: bib9
  article-title: Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015 Lung cancer screening with low-dose computed TomographyLetters
  publication-title: JAMA Oncol.
– volume: 365
  start-page: 395
  year: 2011
  end-page: 409
  ident: bib39
  article-title: Reduced lung-cancer mortality with low-dose computed tomographic screening
  publication-title: N. Engl. J. Med.
– volume: 14
  start-page: 120
  year: 2011
  end-page: 126
  ident: bib14
  article-title: Estimates of lung cancer mortality at the province level in China
  publication-title: Zhongguo Fei Ai Za Zhi
– volume: 291
  start-page: 1763
  year: 2004
  end-page: 1768
  ident: bib16
  article-title: Lung cancer in US women a contemporary epidemic
  publication-title: J. Am. Med. Assoc.
– volume: 8
  start-page: 43322
  year: 2017
  end-page: 43331
  ident: bib24
  article-title: Relationship between exposure to PM2.5 and lung cancer incidence and mortality: a meta-analysis
  publication-title: Oncotarget
– volume: 165
  start-page: 277
  year: 2002
  end-page: 304
  ident: bib2
  article-title: American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, june 2001 and by the ERS executive committee, june 2001
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 525
  start-page: 367
  year: 2015
  end-page: 371
  ident: bib20
  article-title: The contribution of outdoor air pollution sources to premature mortality on a global scale
  publication-title: Nature
– volume: 19
  start-page: 702
  year: 2008
  end-page: 710
  ident: bib21
  article-title: Long-term exposure to traffic-related air pollution and lung cancer risk
  publication-title: Epidemiology
– volume: 7
  start-page: 450
  year: 2018
  end-page: 463
  ident: bib7
  article-title: Lung cancer in never smokers-the East Asian experience
  publication-title: Transl. Lung Cancer Res.
– volume: 5
  start-page: 153
  year: 2010
  end-page: 157
  ident: bib36
  article-title: Tgf-beta signaling pathway in lung adenocarcinoma invasion
  publication-title: J. Thorac. Oncol.
– volume: 3
  start-page: 819
  year: 2008
  end-page: 831
  ident: bib4
  article-title: The international epidemiology of lung cancer: geographical distribution and secular trends
  publication-title: J. Thorac. Oncol.
– volume: 5
  start-page: 197
  year: 2014
  end-page: 203
  ident: bib12
  article-title: Demonstration program of population-based lung cancer screening in China: rationale and study design
  publication-title: Thorac Cancer
– volume: 221
  start-page: 587
  year: 2001
  end-page: 591
  ident: bib13
  article-title: CT screening for lung cancer: not ready for routine practice
  publication-title: Radiology
– volume: vol. 143
  start-page: e30S
  year: 2013
  end-page: e39S
  ident: bib38
  article-title: Molecular biology of lung cancer: diagnosis and management of lung cancer
  publication-title: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest
– start-page: 85
  year: 2019
  ident: bib3
  article-title: Global epidemiology of lung cancer
  publication-title: Ann Glob Health
– volume: 14
  start-page: 1262
  year: 2013
  end-page: 1263
  ident: bib19
  article-title: The carcinogenicity of outdoor air pollution
  publication-title: Lancet Oncol.
– volume: 71
  start-page: 6665
  year: 2011
  end-page: 6675
  ident: bib35
  article-title: Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-beta type II receptor
  publication-title: Cancer Res.
– volume: 579
  start-page: 1460
  year: 2017
  end-page: 1466
  ident: bib23
  article-title: The burden of lung cancer mortality attributable to fine particles in China
  publication-title: Sci. Total Environ.
– volume: 381
  start-page: 705
  year: 2019
  end-page: 715
  ident: bib29
  article-title: Ambient particulate air pollution and daily mortality in 652 cities
  publication-title: N. Engl. J. Med.
– volume: 106
  start-page: 21063
  year: 2009
  end-page: 21067
  ident: bib25
  article-title: Inhalation exposure to ambient polycyclic aromatic hydrocarbons and lung cancer risk of Chinese population
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 47
  start-page: 170
  year: 2013
  end-page: 182
  ident: bib10
  article-title: Designing and anticipating target of early diagnosis and treatment of urban cancer in China
  publication-title: Chin. J. Prev. Med.
– year: 2014
  ident: bib26
  article-title: Components Necessary for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement
– volume: 121
  start-page: 3157
  year: 2015
  end-page: 3164
  ident: bib40
  article-title: Chinese consensus on early diagnosis of primary lung cancer (2014 version)
  publication-title: Cancer
– volume: 35
  start-page: 143
  year: 2002
  end-page: 148
  ident: bib8
  article-title: Screening for lung cancer: the early lung cancer action approach
  publication-title: Lung Cancer
– volume: 17
  start-page: e45
  year: 2016
  end-page: e56
  ident: bib33
  article-title: Assessment of selection criteria for low-dose lung screening CT among Asian ethnic groups in taiwan: from mass screening to specific risk-based screening for non-smoker lung cancer
  publication-title: Clin. Lung Cancer
– volume: 66
  start-page: 115
  year: 2016
  end-page: 132
  ident: bib1
  article-title: Cancer statistics in China, 2015
  publication-title: CA A Cancer J. Clin.
– volume: 6
  start-page: 385
  year: 2015
  end-page: 389
  ident: bib11
  article-title: Early detection of lung cancer: low-dose computed tomography screening in China
  publication-title: Thorac cancer
– volume: 20
  start-page: 1098
  year: 2019
  end-page: 1108
  ident: bib28
  article-title: 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study
  publication-title: Lancet Oncol.
– volume: 172
  start-page: 729
  year: 2005
  end-page: 737
  ident: bib34
  article-title: Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 277
  start-page: 555
  year: 2015
  end-page: 564
  ident: bib32
  article-title: CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds
  publication-title: Radiology
– volume: 74
  start-page: 7
  year: 2011
  end-page: 11
  ident: bib37
  article-title: Do all lung adenocarcinomas follow a stepwise progression?
  publication-title: Lung Cancer
– volume: 208
  start-page: 1011
  year: 2017
  end-page: 1021
  ident: bib31
  article-title: Lung cancers manifesting as part-solid nodules in the national lung screening trial
  publication-title: AJR Am. J. Roentgenol.
– volume: 12
  year: 2017
  ident: bib27
  article-title: Evaluating lung cancer screening in China: implications for eligibility criteria design from a microsimulation modeling approach
  publication-title: PLoS One
– volume: 273
  start-page: 591
  year: 2014
  end-page: 596
  ident: bib30
  article-title: CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases
  publication-title: Radiology
– year: 2001
  ident: bib17
  article-title: A Report of the Surgeon General
– volume: 19
  start-page: 1284
  year: 2010
  end-page: 1291
  ident: bib22
  article-title: Air pollution from traffic and risk for lung cancer in three Danish cohorts
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 27
  start-page: 3
  year: 2000
  end-page: 18
  ident: bib18
  article-title: Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis
  publication-title: Lung Cancer
– volume: 121
  start-page: 3097
  year: 2015
  end-page: 3106
  ident: bib15
  article-title: Emerging tobacco-related cancer risks in China: a nationwide, prospective study of 0.5 million adults
  publication-title: Cancer
– volume: 121
  start-page: 4341
  year: 2015
  end-page: 4347
  ident: bib41
  article-title: Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening
  publication-title: Cancer
– volume: 25
  start-page: 472
  year: 2007
  end-page: 478
  ident: bib6
  article-title: Lung cancer incidence in never smokers
  publication-title: J. Clin. Oncol.
– volume: 25
  start-page: 907
  year: 1996
  end-page: 912
  ident: bib5
  article-title: Cancer mortality of Chinese in New York city 1988-1992
  publication-title: Int. J. Epidemiol.
– volume: 12
  year: 2017
  ident: 10.1016/j.canlet.2019.10.009_bib27
  article-title: Evaluating lung cancer screening in China: implications for eligibility criteria design from a microsimulation modeling approach
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0173119
– volume: 165
  start-page: 277
  year: 2002
  ident: 10.1016/j.canlet.2019.10.009_bib2
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/ajrccm.165.2.ats01
– volume: vol. 143
  start-page: e30S
  year: 2013
  ident: 10.1016/j.canlet.2019.10.009_bib38
  article-title: Molecular biology of lung cancer: diagnosis and management of lung cancer
– volume: 17
  start-page: e45
  year: 2016
  ident: 10.1016/j.canlet.2019.10.009_bib33
  article-title: Assessment of selection criteria for low-dose lung screening CT among Asian ethnic groups in taiwan: from mass screening to specific risk-based screening for non-smoker lung cancer
  publication-title: Clin. Lung Cancer
  doi: 10.1016/j.cllc.2016.03.004
– volume: 579
  start-page: 1460
  year: 2017
  ident: 10.1016/j.canlet.2019.10.009_bib23
  article-title: The burden of lung cancer mortality attributable to fine particles in China
  publication-title: Sci. Total Environ.
  doi: 10.1016/j.scitotenv.2016.11.147
– volume: 121
  start-page: 3157
  issue: Suppl 17
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib40
  article-title: Chinese consensus on early diagnosis of primary lung cancer (2014 version)
  publication-title: Cancer
  doi: 10.1002/cncr.29571
– volume: 14
  start-page: 120
  year: 2011
  ident: 10.1016/j.canlet.2019.10.009_bib14
  article-title: Estimates of lung cancer mortality at the province level in China
  publication-title: Zhongguo Fei Ai Za Zhi
– volume: 121
  start-page: 3097
  issue: Suppl 17
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib15
  article-title: Emerging tobacco-related cancer risks in China: a nationwide, prospective study of 0.5 million adults
  publication-title: Cancer
  doi: 10.1002/cncr.29560
– year: 2001
  ident: 10.1016/j.canlet.2019.10.009_bib17
– volume: 27
  start-page: 3
  year: 2000
  ident: 10.1016/j.canlet.2019.10.009_bib18
  article-title: Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis
  publication-title: Lung Cancer
  doi: 10.1016/S0169-5002(99)00093-8
– volume: 7
  start-page: 450
  year: 2018
  ident: 10.1016/j.canlet.2019.10.009_bib7
  article-title: Lung cancer in never smokers-the East Asian experience
  publication-title: Transl. Lung Cancer Res.
  doi: 10.21037/tlcr.2018.05.14
– volume: 74
  start-page: 7
  year: 2011
  ident: 10.1016/j.canlet.2019.10.009_bib37
  article-title: Do all lung adenocarcinomas follow a stepwise progression?
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2011.05.021
– volume: 5
  start-page: 197
  year: 2014
  ident: 10.1016/j.canlet.2019.10.009_bib12
  article-title: Demonstration program of population-based lung cancer screening in China: rationale and study design
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.12078
– volume: 291
  start-page: 1763
  year: 2004
  ident: 10.1016/j.canlet.2019.10.009_bib16
  article-title: Lung cancer in US women a contemporary epidemic
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.291.14.1763
– volume: 25
  start-page: 907
  year: 1996
  ident: 10.1016/j.canlet.2019.10.009_bib5
  article-title: Cancer mortality of Chinese in New York city 1988-1992
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/25.5.907
– volume: 19
  start-page: 702
  year: 2008
  ident: 10.1016/j.canlet.2019.10.009_bib21
  article-title: Long-term exposure to traffic-related air pollution and lung cancer risk
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e318181b3ca
– volume: 19
  start-page: 1284
  year: 2010
  ident: 10.1016/j.canlet.2019.10.009_bib22
  article-title: Air pollution from traffic and risk for lung cancer in three Danish cohorts
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-10-0036
– volume: 71
  start-page: 6665
  year: 2011
  ident: 10.1016/j.canlet.2019.10.009_bib35
  article-title: Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-beta type II receptor
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-11-1590
– volume: 14
  start-page: 1262
  year: 2013
  ident: 10.1016/j.canlet.2019.10.009_bib19
  article-title: The carcinogenicity of outdoor air pollution
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(13)70487-X
– volume: 20
  start-page: 1098
  year: 2019
  ident: 10.1016/j.canlet.2019.10.009_bib28
  article-title: 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(19)30329-8
– volume: 273
  start-page: 591
  year: 2014
  ident: 10.1016/j.canlet.2019.10.009_bib30
  article-title: CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases
  publication-title: Radiology
  doi: 10.1148/radiol.14132950
– volume: 3
  start-page: 1278
  year: 2017
  ident: 10.1016/j.canlet.2019.10.009_bib9
  article-title: Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015 Lung cancer screening with low-dose computed TomographyLetters
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2016.6416
– volume: 25
  start-page: 472
  year: 2007
  ident: 10.1016/j.canlet.2019.10.009_bib6
  article-title: Lung cancer incidence in never smokers
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2006.07.2983
– volume: 365
  start-page: 395
  year: 2011
  ident: 10.1016/j.canlet.2019.10.009_bib39
  article-title: Reduced lung-cancer mortality with low-dose computed tomographic screening
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1102873
– volume: 121
  start-page: 4341
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib41
  article-title: Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening
  publication-title: Cancer
  doi: 10.1002/cncr.29677
– year: 2014
  ident: 10.1016/j.canlet.2019.10.009_bib26
– volume: 47
  start-page: 170
  year: 2013
  ident: 10.1016/j.canlet.2019.10.009_bib10
  article-title: Designing and anticipating target of early diagnosis and treatment of urban cancer in China
  publication-title: Chin. J. Prev. Med.
– volume: 8
  start-page: 43322
  year: 2017
  ident: 10.1016/j.canlet.2019.10.009_bib24
  article-title: Relationship between exposure to PM2.5 and lung cancer incidence and mortality: a meta-analysis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17313
– volume: 66
  start-page: 115
  year: 2016
  ident: 10.1016/j.canlet.2019.10.009_bib1
  article-title: Cancer statistics in China, 2015
  publication-title: CA A Cancer J. Clin.
– volume: 6
  start-page: 385
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib11
  article-title: Early detection of lung cancer: low-dose computed tomography screening in China
  publication-title: Thorac cancer
  doi: 10.1111/1759-7714.12253
– volume: 525
  start-page: 367
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib20
  article-title: The contribution of outdoor air pollution sources to premature mortality on a global scale
  publication-title: Nature
  doi: 10.1038/nature15371
– volume: 381
  start-page: 705
  year: 2019
  ident: 10.1016/j.canlet.2019.10.009_bib29
  article-title: Ambient particulate air pollution and daily mortality in 652 cities
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1817364
– volume: 221
  start-page: 587
  year: 2001
  ident: 10.1016/j.canlet.2019.10.009_bib13
  article-title: CT screening for lung cancer: not ready for routine practice
  publication-title: Radiology
  doi: 10.1148/radiol.2213001643
– volume: 3
  start-page: 819
  year: 2008
  ident: 10.1016/j.canlet.2019.10.009_bib4
  article-title: The international epidemiology of lung cancer: geographical distribution and secular trends
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0b013e31818020eb
– volume: 277
  start-page: 555
  year: 2015
  ident: 10.1016/j.canlet.2019.10.009_bib32
  article-title: CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds
  publication-title: Radiology
  doi: 10.1148/radiol.2015142554
– start-page: 85
  year: 2019
  ident: 10.1016/j.canlet.2019.10.009_bib3
  article-title: Global epidemiology of lung cancer
  publication-title: Ann Glob Health
– volume: 35
  start-page: 143
  year: 2002
  ident: 10.1016/j.canlet.2019.10.009_bib8
  article-title: Screening for lung cancer: the early lung cancer action approach
  publication-title: Lung Cancer
  doi: 10.1016/S0169-5002(01)00416-0
– volume: 208
  start-page: 1011
  year: 2017
  ident: 10.1016/j.canlet.2019.10.009_bib31
  article-title: Lung cancers manifesting as part-solid nodules in the national lung screening trial
  publication-title: AJR Am. J. Roentgenol.
  doi: 10.2214/AJR.16.16930
– volume: 172
  start-page: 729
  year: 2005
  ident: 10.1016/j.canlet.2019.10.009_bib34
  article-title: Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.200504-615OC
– volume: 5
  start-page: 153
  year: 2010
  ident: 10.1016/j.canlet.2019.10.009_bib36
  article-title: Tgf-beta signaling pathway in lung adenocarcinoma invasion
  publication-title: J. Thorac. Oncol.
  doi: 10.1097/JTO.0b013e3181c8cc0c
– volume: 106
  start-page: 21063
  year: 2009
  ident: 10.1016/j.canlet.2019.10.009_bib25
  article-title: Inhalation exposure to ambient polycyclic aromatic hydrocarbons and lung cancer risk of Chinese population
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0905756106
SSID ssj0005475
Score 2.6784139
SecondaryResourceType review_article
Snippet Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease...
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 82
SubjectTerms Air pollution
Cancer screening
Epidemiology
ETS
Incidence
LDCT
Legislation
Lung cancer
Mortality
PM2.5
Pollutants
Risk factors
Smoking
Trends
Womens health
Title Epidemiology of lung cancer and lung cancer screening programs in China and the United States
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0304383519305002
https://dx.doi.org/10.1016/j.canlet.2019.10.009
https://www.proquest.com/docview/2311904400
https://www.proquest.com/docview/2305030830
Volume 468
WOSCitedRecordID wos000497256700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: ScienceDirect database
  customDbUrl:
  eissn: 1872-7980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0005475
  issn: 0304-3835
  databaseCode: AIEXJ
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZZO8ZeRnej6bqiwV5dfJFm-bG0KevYymBheA_DyLIELsEpbdzmZf99R1cnDaPdYC8mViRb1vl09Ek6Rweh94wokiRcRrTWSzcqzqJa98dC6KBpwNC5Cd_2_XN-fs7Ksvg6Gv3yvjA3s7zr2HJZXP5XUUMaCFu7zv6FuMNDIQF-g9DhCmKH64MEPxlivprd81mv3Wq1cK255Oo96AyYx1qHdGOnZaxjTUztYFq5xkpXueyxfcbMOAQFav7DLUCf8FvZBnOftje6nrtx0iydtna7v--W_bBB5EqXgNpm7nK7RYk0vrMosektYz209C4Ms8eTHEqrcFkODL-w0Zy8RiY20o7TqTY40drovKH37RLEBczpO_hqbbFXHBqjvWIY54L14TddEV0PIK8xNUeRbqc5LUApbh-dTcpPg40QMSc1h4p730tjILj5rj9xmzujvKEu0x30zM058JHFynM0kt0L9OSLs6p4iX6uQgbPFdYQwRYiGOSwdh8ggz1kcNthAxmTFyCDLWSwhcwrND2dTI8_Ri7sRiRIGi-iRklFPiQ1EYpCR2aqoYLThNOioUnOgLIKolLOgXg2eqcOJsypAF4vkowqEWev0VY37-QuwjIFDRETQmvFCU0ly5qiIWnSCCBBda3GKPPtVQl3JL2OjDKrvO3hRWVbudKtrFOhlccoCqUu7ZEs9-SnXhSVdzeGAbIC7NxTLg_lHB21NPMBJfe9xCunGa4rmEgB-SYwZo7Ru_A3KHO9Q8c7Oe91Hn08E8yK4r1_fvkb9HTokftoa3HVy7fosbhZtNdXB-hRXrIDh_PfSnnGqA
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+lung+cancer+and+lung+cancer+screening+programs+in+China+and+the+United+States&rft.jtitle=Cancer+letters&rft.au=Yang%2C+Dawei&rft.au=Liu%2C+Yang&rft.au=Bai%2C+Chunxue&rft.au=Wang%2C+Xiandong&rft.date=2020-01-01&rft.pub=Elsevier+B.V&rft.issn=0304-3835&rft.eissn=1872-7980&rft.volume=468&rft.spage=82&rft.epage=87&rft_id=info:doi/10.1016%2Fj.canlet.2019.10.009&rft.externalDocID=S0304383519305002
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3835&client=summon